Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Toxicol Lett. 2020 Nov 27;338:10–20. doi: 10.1016/j.toxlet.2020.11.015

Figure 3. Recombinant P450 screen for sudoxicam and meloxicam bioactivation.

Figure 3.

(A.) 400 µM sudoxicam and (B.) 400 µM meloxicam were incubated with recombinant P450s to measure glyoxal (green circles) and methylglyoxal (purple squares) formation. Significant differences from background (dashed line) were determined based on p < 0.05 calculated using Student’s T test. Error bars denote standard error. (2 column)